Press Releases :: NeoGenomics, Inc. (NEO)

NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling

NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types

NeoGenomics to Participate in Upcoming Investor Conferences

Menu

Test Search

Year

Category

Jul 1, 2025 7:05 am EDT

NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025

Jun 30, 2025 7:05 am EDT

NeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care

Jun 24, 2025 7:05 am EDT

NeoGenomics Appoints Dr. Marjorie Green to Board of Directors

May 28, 2025 7:10 am EDT

NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025

May 22, 2025 7:10 am EDT

NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer

May 20, 2025 7:05 am EDT

NeoGenomics to Participate in Upcoming June Investor Conferences

May 1, 2025 7:05 am EDT

NeoGenomics Pays Off 1.25% Convertible Senior Notes

Apr 29, 2025 7:30 am EDT

NeoGenomics Reports First Quarter 2025 Results

Apr 22, 2025 7:05 am EDT

NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting

Apr 8, 2025 7:05 am EDT

NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025